Christoph Oing

Christoph Oing is a Research Fellow and Functional Senior Physician at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the II. Medical Clinic and Polyclinic within the Faculty of Medicine. His primary role involves clinical oncology with a focus on hematological malignancies and solid tumors, particularly testicular and prostate cancers. He holds the 2014 UCCH Fellowship and is a member of professional societies including DGHO, EACR, and BDI.

Research & Clinical Focus: Dr. Oing specializes in germ cell tumors and metastatic prostate cancer, investigating therapeutic strategies like PARP inhibitors, high-dose chemotherapy, and targeted therapies. His work emphasizes interdisciplinary collaboration in treatment protocols and diagnostic advancements. He has contributed to international guidelines such as the EAU Testicular Cancer Guidelines and ESMO resilience initiatives during the pandemic.

Recent Contributions: Key research includes studies on cisplatin resistance mechanisms, oligometastatic bladder cancer diagnosis, and patient-derived tumor modeling for personalized therapy. His publications span oncology journals like European Urology and Molecular Oncology.

Awards & Recognition: Recipient of the UCCH Fellowship (2014), recognizing his early-career contributions to oncology research and clinical innovation.